By Dawood Fakhir ( August 6, 2025, 2:31 PM BST) -- Sanofi said Wednesday that it has completed the approximately $470 million acquisition of U.S. biotechnology company Vigil Neuroscience, which specializes in neurodegenerative diseases, strengthening the French pharma titan's early-stage medicine pipeline in neurology....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.